about
Tackling ALK in non-small cell lung cancer: the role of novel inhibitorsThe Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection.Prevalence and prognostic significance of microsatellite alterations in young patients with bladder cancer.Bronchial typical carcinoid tumors.Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer.Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRbeta mutation.Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alphaA phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer.Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.Epithelioid sarcoma of the penis: a case report and review of the literature.Biological prognostic and predictive factors in lung cancer.Cystic paraganglioma of the renal capsule.Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsSubcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. A phase II study and review of the literature.Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practiceThe value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumourThe role of new targeted therapies in small-cell lung cancer.Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.Mucorales-Specific T Cells in Patients with Hematologic Malignancies.Treatment of locally advanced non-small cell lung cancer in the elderly.Chemotherapy of advanced non-small cell lung cancer in elderly patients.Chemotherapy of advanced NSCLC in special patient population.Bronchopulmonary actinomycosis associated with hiatal hernia.Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development.Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis.Heavily pigmented renal cell carcinoma: a case report, with review of the literature and differential diagnosis.Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations.Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?The histology of pulmonary sarcoidosis: a review with particular emphasis on unusual and underrecognized features.Surgical management of non-small cell lung cancer with mediastinal lymphadenopathy.Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.The role of histology in idiopathic pulmonary fibrosis: an update.Advances in chemotherapy in advanced non-small-cell lung cancer.
P50
Q26740329-E1630890-4CF7-4EB0-A58B-E1FE287EF5EAQ30249696-CBD4ACB7-1CA2-4EBA-9E29-C7C733EB15BAQ30852820-6DBBE59E-C25A-4B6B-8BCD-DC8F03BA178AQ31098534-D6A63BC7-667D-4718-868A-D099E523AD9AQ31161907-951B354C-E240-410C-99C4-EE35A862493AQ33267429-FB4967A4-16A3-4E07-B773-BA45AE8EACBEQ33311606-21B779B8-FC31-4295-B73F-8D3D91C02D3FQ33349796-251C2444-3404-4025-90F4-11140A9FBDC6Q33372219-80E5D9C1-AECC-441D-9589-6E7950000308Q33374797-5508B62B-430C-4A2F-BA97-D2A8542BA1E5Q33380939-6FD5A7B5-BFA1-41A8-8299-F035049A9056Q33409103-0992203C-0A95-4CA0-BFFD-3F3D963FA38FQ33497773-A8B61824-1B8D-4C55-BA34-744B4474A075Q33962312-E34E3DBE-CBC8-484A-AF7F-09FED15F567CQ34096776-BCFBFBA9-7322-42E7-9813-38B224DE331CQ34140100-6DC96672-18D2-4943-B1AA-AD6A2BBE7B6CQ34219342-0252D31A-1FC9-431C-BB0F-07BC353FFA46Q34359601-F99BA173-A781-4D4A-B228-9FC88113E4C1Q34984670-9914A2FC-BBE4-4329-964E-421F87C0DD02Q35132240-B95302FC-CECF-428F-943C-CB4A5052AD66Q35200569-B9890738-A086-40D5-A74E-525E32809850Q35588963-04877126-66E6-4568-8B41-E235CCF67F02Q35810726-3E88AFD5-978D-41F4-9666-C1CE1486EAE8Q35896202-31B59F62-4B46-4A75-B3DA-895B7611B2A2Q35922089-7D7D38A6-092A-4944-A1D4-3EF129A24B86Q36051929-004E4F8C-9C57-47CF-AB2F-14C5FEC15FC6Q36445847-9AA5FAB0-344D-4BCB-BBC0-1ADA6F8F1F6AQ36522777-E3F1A8E6-4B26-4024-A383-B8A1819B7A50Q37148375-16631940-8265-4BD9-9F2C-74BAC153DC1AQ37218411-4480F8FC-FCAB-46EE-A0BB-BF0BA1EABAFBQ37221105-FA785511-A470-4B56-9DD6-46678568B640Q37243117-773CE391-56F9-4F7E-A061-DE6BAC0F8981Q37360492-DF6E37F1-6AC1-447A-9406-AAD31A7281A6Q37397647-DBA49143-24DA-4886-BCD5-8862B8615EE5Q37425822-2C91C88F-9F25-4D1F-956E-40D62018D6F1Q37483167-6B178A95-FB82-4C18-97E8-4A4F6D5BA266Q37692643-B62C4B64-8597-4D7F-B868-1340FC218153Q37699578-C9036AC2-8CBF-4389-AE94-7D9D3A223CD4Q37752765-966B0A93-32C4-4A48-9547-441DD913B092Q37779321-1115534F-D554-496E-BE45-85AF2FB9FFE2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Rossi
@ast
Antonio Rossi
@en
Antonio Rossi
@es
Antonio Rossi
@nl
Antonio Rossi
@sl
type
label
Antonio Rossi
@ast
Antonio Rossi
@en
Antonio Rossi
@es
Antonio Rossi
@nl
Antonio Rossi
@sl
prefLabel
Antonio Rossi
@ast
Antonio Rossi
@en
Antonio Rossi
@es
Antonio Rossi
@nl
Antonio Rossi
@sl
P1053
K-7054-2016
P106
P1153
56703645800
P21
P31
P3829
P496
0000-0003-3295-0345